Aprea Therapeutics, Inc. (APRE)
0.7833
+0.01
(+1.21%)
USD |
NASDAQ |
Sep 14, 14:22
Aprea Therapeutics Price to Book Value : 0.2523 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.2493 |
| September 10, 2026 | 0.2542 |
| September 09, 2026 | 0.2549 |
| September 08, 2026 | 0.2689 |
| September 04, 2026 | 0.2558 |
| September 03, 2026 | 0.2597 |
| September 02, 2026 | 0.2641 |
| September 01, 2026 | 0.2692 |
| August 31, 2026 | 0.2577 |
| August 28, 2026 | 0.2701 |
| August 27, 2026 | 0.277 |
| August 26, 2026 | 0.3157 |
| August 25, 2026 | 0.306 |
| August 24, 2026 | 0.2594 |
| August 21, 2026 | 0.2062 |
| August 20, 2026 | 0.2062 |
| August 19, 2026 | 0.2161 |
| August 18, 2026 | 0.2164 |
| August 17, 2026 | 0.2222 |
| August 14, 2026 | 0.219 |
| August 13, 2026 | 0.2161 |
| August 12, 2026 | 0.22 |
| August 11, 2026 | 0.2126 |
| August 10, 2026 | 0.2075 |
| August 07, 2026 | 0.2095 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.2037 |
| August 05, 2026 | 0.20 |
| August 04, 2026 | 0.193 |
| August 03, 2026 | 0.1925 |
| July 31, 2026 | 0.1997 |
| July 30, 2026 | 0.2045 |
| July 29, 2026 | 0.20 |
| July 28, 2026 | 0.1977 |
| July 27, 2026 | 0.2012 |
| July 24, 2026 | 0.2036 |
| July 23, 2026 | 0.2032 |
| July 22, 2026 | 0.2126 |
| July 21, 2026 | 0.21 |
| July 20, 2026 | 0.2155 |
| July 17, 2026 | 0.2285 |
| July 16, 2026 | 0.2222 |
| July 15, 2026 | 0.2248 |
| July 14, 2026 | 0.2346 |
| July 13, 2026 | 0.2326 |
| July 10, 2026 | 0.24 |
| July 09, 2026 | 0.2345 |
| July 08, 2026 | 0.2391 |
| July 07, 2026 | 0.248 |
| July 06, 2026 | 0.2416 |
| July 02, 2026 | 0.2387 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Zymeworks, Inc. | 24.05 |
| Rhythm Pharmaceuticals, Inc. | 68.27 |
| Onconetix, Inc. | 0.1825 |
| ACADIA Pharmaceuticals, Inc. | 3.635 |
| Alnylam Pharmaceuticals, Inc. | 24.55 |
Price to Book Value Related Metrics
| PS Ratio | 3096.66 |
| Price | 0.7833 |
| Earnings Yield | -137.5% |
| Market Cap | 9.706M |